user

COST MINIMISATION ANALYSIS OF FOLLITROPIN DELTA VERSUS FOLLITROPIN ALFA IN ASSISTED REPRODUCTIVE TECHNOLOGIES (IVF/ICSI) IN THE UNITED KINGDOM

被引：0
|
作者：
Sivignon, M. [1 ]
Palencia, R. [2 ]
Roze, S. [1 ]
机构：
[1] HEVA HEOR Sarl, Lyon, France
[2] Ferring Pharmaceut AS, Copenhagen, Denmark
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.326
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIH21
引用
收藏
页码：A403 / A403
页数：1
相关论文
共 16 条
  • [1] Comparison of follitropin delta versus follitropin alfa in progestin-primed ovarian stimulation in IVF
    Okamoto, E.
    Enatsu, N.
    Yamada, K.
    Yamada, A.
    Hayashi, N.
    Enatsu, Y.
    Katayama, K.
    Tokura, Y.
    Yamada, S.
    Mizusawa, Y.
    Kishi, K.
    Kokeguchi, S.
    Shiotani, M.
    [J]. HUMAN REPRODUCTION, 2023, 38
  • [2] Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers
    Schwarze, Juan-Enrique
    Venetis, Christos
    Iniesta, Silvia
    Falla, Edel
    Lukyanov, Vasily
    Calvo, Elena de Agustin
    D 'Hooghe, Thomas
    Roeder, Claudia
    Matorras, Roberto
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2022, 85 : 203 - 216
  • [3] A systematic review and meta-analysis comparing Biosimilar versus Originator Recombinant Follitropin Alfa in women undergoing IVF/ICSI
    Longobardi, S.
    Mol, B.
    Chua, S. J.
    Wang, R.
    Venetis, C.
    Papsch, R.
    Trew, G. H.
    Orvieto, R.
    D'Hooghe, T.
    [J]. HUMAN REPRODUCTION, 2019, 34 : 106 - 106
  • [4] Outcome of pregnancies derived from assisted reproductive technologies: IVF versus ICSI
    Orvieto, R
    Ben-Rafael, Z
    Ashkenazi, J
    Yoeli, R
    Messing, B
    Perri, T
    Shalev, Y
    Bar-Hava, I
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2000, 17 (07) : 385 - 387
  • [5] Outcome of Pregnancies Derived from Assisted Reproductive Technologies: IVF versus ICSI
    R. Orvieto
    Z. Ben-Rafael
    J. Ashkenazi
    R. Yoeli
    B. Messing
    T. Perri
    Y. Shalev
    I. Bar-Hava
    [J]. Journal of Assisted Reproduction and Genetics, 2000, 17 : 385 - 387
  • [6] Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study
    Kaplan, Sigal
    Levy-Toledano, Rachel
    Davies, Miranda
    Roy, Debabrata
    Howles, Colin M.
    Lass, Amir
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [7] Safety of Ovaleap® (Follitropin Alfa) in infertile women undergoing superovulation for assisted reproductive technologies (SOFIA): A multinational comparative, prospective cohort study
    Kaplan, Sigal
    Toledano, Rachel
    Davies, Miranda
    Roy, Debabrata
    Howles, Colin
    Lass, Amir
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 334 - 334
  • [8] COST-EFFECTIVENESS ANALYSIS OF LONG-ACTING RECOMBINANT FSH (CORIFOLLITROPIN ALFA) VERSUS RECOMBINANT FSH (FOLLITROPIN ALFA) IN ASSISTED REPRODUCTION TECHNIQUES IN THE MANAGEMENT OF INFERTILITY IN IRAN
    Taheri, S.
    Tahmasebi, N.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A521 - A521
  • [9] Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
    Chua, Su Jen
    Mol, Ben W.
    Longobardi, Salvatore
    Orvieto, Raoul
    Venetis, Christos A.
    Lispi, Monica
    Storr, Ashleigh
    D'Hooghe, Thomas
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2021, 19 (01)
  • [10] Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
    Su Jen Chua
    Ben W. Mol
    Salvatore Longobardi
    Raoul Orvieto
    Christos A. Venetis
    Monica Lispi
    Ashleigh Storr
    Thomas D’Hooghe
    [J]. Reproductive Biology and Endocrinology, 19
12